IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02716311Combination of Cetuximab With Afatinib for Patient With EGFR Mutated Lung Cancer
NCT02183883Deciphering Afatinib Response and Resistance With INtratumour Heterogeneity
NCT02597946Afatinib in NSCLC With HER2 Mutation